Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic studies of tacrolimus in transplant patients

X
Trial Profile

Pharmacokinetic studies of tacrolimus in transplant patients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Mar 2018

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Liver transplant rejection; Renal transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Mar 2018 Results of analysis comparing simulated PK profiles with observed PK data to evaluate the influence of CYP3A4 abundance, hematocrit, serum albumin and creatinine levels on PK variability observed in renal transplant patients presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 24 Mar 2018 Results (n=35) assessing relationship between patient genotype and dose normalized PK parameters presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 28 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top